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1. Introduction  
Lung cancer is the most common cancer in the world with 1.61 million new cases diagnosed 
every year (1). The vast majority of lung cancers are caused by cigarette smoking. It has been 
estimated that the lifetime risk of developing lung cancer in 2008 is 1 in 14 for men and 1 in 
19 for women in the UK.  
Approximately 2400 Lobectomies and 500 Pneumonectomies are undertaken in the UK 
annually, the majority for malignancy. For this group of patients, in-hospital mortality rates 
are 2-4% and 6-8% respectively in the UK, although world mortality rates as high as 11% 
have been cited for Pneumonectomy(2) 
To guide decisions, one must not only consider the extremely poor prognosis for inoperable 
patients  but also  be familiar with the operative risks, and understand how surgery impacts 
on pulmonary function both  in short term and long term. 
The aim of the preoperative pulmonary assessment is to identify patients who are at 
increased risk of having peri-operative complications and long term disability from surgical 
resection using the least tests available. The purpose of this preoperative physiologic 
assessment is to enable adequate counselling of the patient on treatment options and risks so 
that they can make a truly informed decision (3) 
Preoperative evaluation of a patient with lung cancer involves answering three questions: 1) 
is the neoplasm resectable? (Anatomic resectability), 2) Does the patient have adequate 
pulmonary reserve to tolerate pulmonary resection? (Operability or physiologic 
resectability); 3) is there any major medical contraindication to the proposed surgery? 
2. Anatomical resectability 
After a tissue diagnosis of lung cancer has been made, the neoplasm should first be assessed 
for anatomic resectability. A neoplasm is considered resectable if the entire tumour can be 
removed by surgery. Knowing the extent of tumour both within and outside the thorax is 
the key in determining resectability. Surgical resection is considered the treatment of choice 
in physiologically operable patients with up to stage IIIA tumour. (4) 
2.1 Operability (physiologic resectability) 
2.1.1 Physiologic alterations after thoracotomy and lung resection 
If, after adequate staging, the tumour is found to be anatomically resectable, the next step is 
determination of operability or physiological resectability. To understand operability the 
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physiologic changes due to surgery and the pulmonary reserve require discussion. When 
thoracic surgery is performed, several physiological effects occur which can be discussed 
under changes in Lung volume, compliance and pulmonary blood flow. 
2.1.1.1 Changes in lung volume 
Even if no lung is resected, vital capacity declines by approximately 25% in the early 
postoperative period and slowly returns to baseline in a few weeks. In patients with 
underlying lung disease, the reduction in vital capacity by lung surgery may result in 
acute and chronic respiratory failure, or even death. However, it should be noted that 
while in most circumstances lung resection leads to reduction in lung function; this is not 
always the case. Patients who undergo resection of large bullae may actually have 
improvement in lung function postoperatively because of better lung mechanics. On 
occasion, lung resection only involves removal of non-functioning lung parenchyma and 
there is little or no change in resultant lung function after recovery. Moreover, in some 
highly selected cases, in particular upper lobe tumours in patients with centrilobular 
emphysema, there may be a lung volume reduction surgery (LVRS)-like effect. In these 
selected circumstances, the resultant lung function after recovery from resection is 
actually better than the preoperative measurements. This effect is difficult to anticipate 
given the obvious important differences between lobectomy and LVRS protocols, but it 
has been noticed in anecdotal cases (8). 
2.1.1.2 Changes in lung compliance 
Chest wall compliance also decreases to less than 50% and work of breathing increases to 
more than 140% of the preoperative level. The cough pressure is reduced to 30% of the 
preoperative value and increases to 50% by 1 week (5–7). 
2.1.1.3 Changes in pulmonary blood flow 
Removal of lung parenchyma results in reduction of the pulmonary capillary bed. The 
decrease in pulmonary capillary bed is well tolerated by patients with otherwise normal 
lungs but in patients with pulmonary dysfunction this may result in postoperative 
pulmonary hypertension. 
Unlike most general surgical procedures where cardiovascular complications are the 
major cause of perioperative morbidity and mortality, in thoracic surgical population 
respiratory complications are the predominant cause of perioperative morbidity and 
mortality (9,10). 
The principles described will apply to all other types of non-malignant pulmonary 
resections and to other chest surgery. The major difference is that in patients with 
malignancy the risk/benefit ratio of cancelling or delaying surgery pending other 
investigation/therapy is always complicated by the risk of further spread of cancer during 
any extended interval prior to resection. This is never completely “elective” surgery (10). 
3. Assessment of patients for lung resection 
Each patient’s management requires planning by a multi-disciplinary team (MDT), which 
includes a respiratory physician, a thoracic surgeon, an oncologist and other staff such as 
physiotherapists and respiratory nurses. If the MDT feels that surgery is appropriate, then 
the surgeon will decide if the tumour is technically resectable based on chest X-ray and CT 
scan images (Figure 1). 
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Fig. 1. Chest X ray and CT scan showing Lung Cancer in Left Lung. 
4. General assessment 
Prevention of postoperative complications requires a detailed medical history and 
examination. History should address the presence of dyspnoea, exercise tolerance, cough, 
and expectoration, wheezing, and smoking status. Examination should also focus on 
respiratory rate, pattern of breathing, wheezing, and body habitus. 
4.1 Assessment of risks of the surgery 
 
 
Fig. 2. Tripartite Risk Assessment. 
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Recent British Thoracic Society guidelines 2010 (BTS) presents a Tripartite risk assessment 
model that considers  risk of operative mortality, risks of perioperative myocardial events 
and risk of postoperative dyspnoea. 
This model facilitate the calculation and assessment of individual outcomes that may be 
discussed by the MDT and enables the patient to make truly informed decision. 
4.2 Assessment of risks of the surgery 
Estimating the risk of in-hospital death is one of the most important considerations for 
surgeons and patients when they evaluate the option of surgery for lung cancer.The 30 day 
mortality for lobectomy and pneumonectomy in England from National Lung Cancer Audit 
is 2.3% and 5.8% respectively. 
Thoracoscore is  currently the largest and most validated global risk score . It is a logistic 
regression derived model which is based on nine variables like Age, sex, ASA score, 
performance status, dyspnoea score, priority of suregry, extent of surgery, malignant 




Methods for using the logistic regression model to predict the risk of in-hospital death: 
1. Odds are calculated with the patient values and the coefficients are determined from 
the regression equation: 
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2. The odds for the predicted probability of in-hospital death are calculated: probablity + 
odds/(1 + odds). 
ASA, American Society of Anesthesiologists.  
4.3 Age 
All patients should have equal access to lung cancer services regardless of age(12). British 
Thoracic Society (BTS) guideline recommendations with regards to age are: 
1. Perioperative morbidity increases with advancing age. The rate of respiratory 
complications (40%) is double that expected in a younger population and the rate of 
cardiac complications (40%), particularly arrhythmias, triples that which should be seen 
in younger patients(10) 
2. Elderly patients undergoing lung resection are more likely to require intensive 
perioperative support. Preoperatively, a careful assessment of co-morbidity needs to be 
made. (13) 
3. Surgery for clinically stage I and II disease can be as effective in patients over 70 years 
as in younger patients. Such patients should be considered for surgical treatment 
regardless of age. (13,14) 
4. Age over 80 alone is not a contraindication to lobectomy or wedge resection for 
clinically stage I disease. 
5. Pneumonectomy is associated with a higher mortality risk in the elderly. Age should be 
a factor in deciding suitability for pneumonectomy 
4.4 Weight loss, performance status and nutrition 
Weight loss>10%, a low BMI or serum albumin may indicate more advanced disease or an 
increased risk of postoperative complications.(16) The National VA Surgical Risk Study 
reported that a low serum albumin level was also the most important predictor of 30-day 
perioperative morbidity and mortality. Mortality increased steadily from less than 1.0% to 
29% as albumin declined from values greater than 4.6 g/dl to values less than 2.1 g/dl.(17) 
4.5 Cardiovascular assessment 
Cardiac complications are the second most common cause of perioperative morbidity and 
mortality in the thoracic surgical population. As with any planned major operation, 
especially in a population that is predisposed to atherosclerotic cardiovascular disease due 
to cigarette smoking, a preoperative cardiovascular risk assessment should be performed. 
The European Respiratory Society/European Society of Thoracic Surgery (ERS/ESTS) 
provides an algorithm based on a well validated score system, the revised cardiac risk index 
(RCRI), to estimate the patient’s risk (18). The calculation of this index is simple, since it is 
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Calculating the revised cardiac risk index (RCRI) based on history, physical examination, 
baseline ECG and serum Creatinine: 
 
Each item is assigned 1 point.
• High Risk Surgery (including Pneumonectomy or Lobectomy) 
• History of Ischemic Heart disease ( Prior MI or Angina pectoris) 
• History of Heart failure 
• Insulin dependent Diabetes 
• Previous Stroke or Transient ischemic attacks 
• Pre-operative Serum Creatinine 2 mg/dl.
If 
• RCRI is ≥ 2 
• The patient has any cardiac conditions requiring medications 
• The patient has a newly suspected cardiac condition 
• The patient is unable to climb 2 flight of stairs
A cardiological consultation is needed.
Table 2. 
Algorithm for cardiac assessment before lung resection for lung cancer patients: 
RCRI: Revised cardiac Risk Index; ECG: electrocardiogram;                                        
AHA: American Heart Association; ACC: American College of Cardiology; 
CABG: coronary artery bypass graft; PCI: primary coronary intervention; 
TIA: transient ischaemic attack 
 
 
Fig. 3.  








Dysrhythmias, particularly atrial fibrillation, are a frequent complication of pulmonary 
resection surgery (8,15). Factors known to correlate with an increased incidence of 
arrhythmia are the amount of lung tissue resected, age, intraoperative blood loss, and intra-
pericardial dissection (16). Prophylactic therapy with Digoxin has not been shown to 
prevent these arrhythmias. Diltiazem has been shown to be effective (22). 
4.7 Smoking 
Smoking cessation should be advised to all patients. Abstinence from smoking will decrease 
carboxyhemoglobin acutely but improvement in mucociliary function and small airway 
obstruction may take up to 10 weeks (21). Stein and Cassara established that 3 weeks of 
smoking cessation combined with perioperative incentive spirometry in a group of patients 
undergoing nonthoracic general surgery improved outcomes (23,24). Three weeks of 
smoking cessation should be considered standard for all non-emergent major surgical 
procedures. 
4.8 COPD 
COPD patients have 6 fold increased risk of post-operative pulmonary complications like 
atelectasis, pneumonia, exacerbation of COPD and Respiratory failure. Inhaled anesthetic 
depresses the respiratory drive in response to both hypoxia and hypercapnia even at sub-
anaesthetic doses. Many COPD patients have an elevated Paco2 at rest. To identify these 
patients preoperatively, all moderate-to-severe COPD patients need arterial blood gas 
analysis. COPD patients desaturate more frequently and severely than normal patients 
during sleep (9). 
As many as 50% of COPD patients will have RV dysfunction mostly due to chronic 
hypoxemia.  The dysfunctional RV is poorly tolerant of sudden increases in afterload such 
as the change from spontaneous to controlled ventilation (9,15). Pneumonectomy candidates 
with a ppoFEV1 ≤40% should have transthoracic echocardiography to assess right heart 
function (23). 
Overall medical condition of patients with COPD who are scheduled for surgery should be 
optimized. Patients with evidence of suboptimal reduction in symptoms, physical 
examination demonstrating airflow obstruction, or submaximal exercise tolerance warrant 
aggressive therapy.  
Use of bronchodilators and glucocorticoid agents, and cessation of smoking, aggressive 
chest physiotherapy are paramount. Antibiotic therapy should be administered if there is 
evidence of pulmonary infection.  
4.9 Renal dysfunction 
Renal dysfunction after pulmonary resection surgery is associated with a very high 
incidence of mortality (19%) (25). History of previous renal dysfunction, concurrent diuretic 
therapy, Pneumonectomy surgery, postoperative infection, and blood transfusion are all 
associated with high risk for perioperative renal dysfunction. Fair evidence supports serum 
blood urea nitrogen levels of 7.5 mmol/L as a risk factor. However, the magnitude of the 
risk seems to be lower than that for low levels of serum albumin. 
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5. Specific assessment 
5.1 Pulmonary function tests & lung resection 
The best assessment of respiratory function comes from a history of the patient’s quality of 
life (9). A unique consideration in patients considered for thoracotomy is the effect of 
pulmonary parenchymal resection on postoperative pulmonary function and exercise 
capacity. There is no single test that can reliably predict the patients’ likelihood of tolerating 
thoracotomy and lung resection without excessive postoperative morbidity and mortality. 
5.2 Current guidelines 
Guidelines from the American College of Chest Physicians and the British Thoracic Society 
suggest that patients with a preoperative Forced Expiratory volume in 1 second (FEV1) in 
excess of 2 L (or >80 percent predicted) generally tolerate pneumonectomy, whereas those 
with a preoperative FEV1 greater than 1.5 L tolerate lobectomy (4,15) However, if there is 
either undue exertional dyspnea or coexistent interstitial lung disease, then measurement of 
Diffusing capacity(DLCO) should also be performed (2). Patients with preoperative results for 
FEV1 and DLCO that are both >80 percent predicted do not need further physiological testing. 
Although pulmonary function that is better than the aforementioned threshold levels predicts 
a good surgical outcome, it has been difficult to identify a single absolute value of preoperative 
FEV1 below which the risk of surgical intervention should be considered prohibitive for all 
patients. Responsible factors for this lack of a single value include the following: 
• Differences in the amount of lung tissue to be resected, as the extent of the planned 
resection will affect the choice of an acceptable preoperative FEV1. 
• Differences in the severity of underlying lung disease and the contribution to total 
lung function of the portion of lung to be resected. 
• Differences in size, age, gender, and race of patients undergoing lung resection. 
Below these values further interpretation of the spirometry readings is needed and a value 
for the predicted postoperative (ppo-) FEV1 should be calculated. As the FEV1 decreases, 
the risk of respiratory and cardiac complications increases, mortality increases and patients 
are more likely to require postoperative ventilation. 
5.3 Calculating the predicted postoperative FEV1(ppo FEV1) & TLCO (ppo TLCO) 
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Radiological imaging (usually a CT scan) identifies the area of the lung that requires 
resection. There are five lung lobes containing nineteen segments in total with the division 
of each lobe (shown in figure 2). 
Knowledge of the number of segments of lung that will be lost by resection allows the 
surgeon and anaesthetist to estimate the post resection spirometry and TLCO values. These 
can then be used to estimate the risk to the patient of undergoing the procedure (22). 
Predicted postoperative function is calculated using preoperative values of FEV1 or DLCO 
and measurement of lobar or whole lung fractional contribution to function as determined 
by quantitative perfusion lung scanning, ventilation, or CT lung scanning. 
no. of segments left after resection
ppo FEV1 = Preoperative FEV1×
18
              
The value obtained is then compared to the predicted value for FEV1 for that individual’s 
height, age, and gender to obtain the percent predicted postoperative FEV1.  
( )ppoDLCO = preoperative DLCO× 1 - %functional lung tissue removed / 100  
Predicted post-operative DLCO is the single strongest predictor of complications and 
mortality after lung resection, although it is important to note that DLCO is NOT predictive 
of long term survival,only perioperative mortality (28). Interestingly, ppoDLCO and 
ppoFEV1 are poorly correlated, and thus should be assessed independently (29) 
A patient is considered to be at increased risk for lung resection with predicted 
postoperative values for either FEV1 or DLCO <40 percent predicted. Nakahara et al. (10) 
found that patients with a ppoFEV1 ≥40% had no or minor post-resection respiratory 
complications. Major respiratory complications were only seen in the subgroup with 
ppoFEV1 ≤40% and patients with ppoFEV1 ≤30% required postoperative mechanical 
ventilatory support. The use of epidural analgesia has decreased the incidence of 
complications in the high-risk group 
The European Respiratory Society and the European Society of Thoracic Surgery 
(ERS/ESTS) advise that the cutoff value for predicted postoperative FEV1 or DLCO may be 
lowered to 30 percent rather than 40 percent, due to improvements in surgical technique 
and the belief that removal of hyperinflated, poorly functioning lung tissue during surgery 
ameliorates the calculated loss in lung function through a “lung volume reduction effect” 
(15,16). However, evaluation with cardiopulmonary exercise testing (CPET) is needed prior 
to making a final decision on operability. 
5.4 Exercise tests 
5.4.1 Formal cardiopulmonary exercise tests 
Exercise tests are thought to mimic the postoperative increase in oxygen consumption and 
have been used to select patients at high risk of cardiopulmonary complications after 
thoracic, but also abdominal surgery. The aim of exercise tests is to stress the whole 
cardiopulmonary system and estimate the physiological reserve that may be available after 
lung resection. The most used and best validated exercise parameter is V’O2, max. In the 
literature, V’O2, max appears to be a very strong predictor of postoperative complications, 
as well as a good predictor of long-term post-operative exercise capacity. 
Patients with a preoperative V’O2, max of 15 to 20 mL/kg/min can undergo curative-intent 
lung cancer surgery with an acceptably low mortality rate.  In several case series, patients 
with a V’O2, max of ≤ 10 mL/kg/min had a very high risk for postoperative death (3,16). 
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Interpreting the VO2 Max 
20 ml/kg/min or > 15ml/kg/min        - No increased risk of complications or death. 
and FEV1 >40% predicted 
 
<15ml/kg/min                                         - High Risk 
 
<10ml/kg/min                                         - 40-50% mortality consider non surgical treatment   
Table 3. 
5.5 Low technology exercise tests 
Formal CPET with VO2‘max measurements may not be readily available in all centres. 
Therefore, low-technology tests have been used to evaluate fitness before lung resection, 
including the 6-min walk test (6MWT), the shuttle test and the stair climbing test. 
5.5.1 6MWT 
The 6MWT is the most used low-technology test, but the distance walked does not correlate 
with the VO2, max in all (especially in fit) patients. Moreover, post-operative complications 
have been found to be associated with the distance walked in some but not all studies. As a 
result, the 6MWT is not recommended to select patients for lung resection (3,19). 
5.5.2 Shuttle walk test 
The shuttle walk test is the distance measured by walking a 10 m distance usually between 
two cones at a pace that is progressively increased. This test has good reproducibility and 
correlates well with formal cardiopulmonary exercising testing (VO2max) (44,45) Previous 
BTS recommendations that the inability to walk 25 shuttles classifies patients as high risk 
has not been reproduced by prospective study(46) Some authors report that shuttle walk 
distance may be useful to stratify low-risk groups (ability to walk >400 m) who would not 
need further formal cardiopulmonary exercise testing.(47)  
5.5.3 Stair climbing test 
Because calculation of VO2 max is expensive, stair climbing has been proposed as an 
alternative. It is commonly cited that the ability to climb five flights of stairs without 
stopping (20 x 6” steps) is equivalent to a VO2 max of 15 mL/kg/min, and two flights 
correspond to 12 mL/kg/min.] However, the data are difficult to interpret as there is a lack 
of standardisation of the height of the stairs, the ceiling heights, different parameters used in 
the assessment (eg, oxygen saturations, extent of lung resection) and different outcomes. 
5.6 Blood gas tension and oxygen saturation at rest 
Recent studies have shown that hypercapnia in itself  is not predictive of complications after 
resection, particularly if patients are able to exercise adequate(28) However, such patients 
are often precluded because of other adverse factors—for example, postoperative FEV1 and 
TLCO <40% predicted. 
Ninan et al found that there was a higher risk of postoperative complications among patients 
who either had oxygen saturation (SaO2) on air at rest of <90% or desaturated by >4% from 
baseline during exercise (34). 
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6. Effects of lung cancer 
Lung cancer patients should be assessed for “4Ms”. 
• Mass effects (SVC, Pancoast, obstructive pneumonia, laryngeal nerve paralysis, 
phrenic paresis)  
• Metabolic effects (hypercalcemia, hyponatremia, Cushing’s, Lambert-Eaton) 
• Metastases to brain, bone, liver& adrenal 
• Medications (bleomycin [avoid high FiO2], cisplatin [avoid NSAIDs]) 
7. Effects of incisions 
FEV1 and FVC are decreased by up to 65% on the first postoperative day after thoracotomy. 
Resolution of these changes takes up to 2 months. The effects can be mitigated somewhat 
through use of appropriate incisions.  
8. Combination of tests 
No single test of respiratory function has shown adequate validity as a sole preoperative 
assessment. Before surgery an estimate of respiratory function in all three areas: lung 
mechanics, parenchymal function, and cardiopulmonary interaction should be made for 
each patient (9). 
Slinger et al has described “The 3-Legged Stool” of Pre-thoracotomy Respiratory 
assessment. 
 
The 3-Legged Stool” of Pre-thoracotomy Respiratory Assessment 
 
 








Respiratory                                       Parenchymal                                    Cardio pulmonary 
Mechanics                                         Function                                            Reserve 
 
FEV1                                                     DLCO                                               VO2 max 15ml/kg/min 
(ppo < 40%)                                         (ppo < 40%) 
 
                                                              PaO2 < 65 mm Hg                           Stair Climb > 2 flights    
 
                                                              PaCo2 > 45 mm Hg                         Exercise SPO2 > 4% fall 
                                                                                                                          from baseline  
 
Courtesy of Slinger and Johnson 
Fig. 5. 
9. Methods of altering the perioperative risks 
The following are the risk-reduction strategies which can be considered to reduce the risks 
in patients undergoing lung resection 
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• Cardiopulmonary rehabilitation 
• Permit recovery from induction therapy 
• Nutritional repletion 
• Smoking cessation 
• DVT and arrhythmia prophylaxis 
• Perioperative pulmonary physiotherapy 
• Changing extent of or approach to operation 
Postoperatively, use of deep-breathing exercises or incentive spirometry, use of continuous 
positive airway pressure, use of epidural analgesia ,use of intercostals nerve blocks where 
applicable helps to reduce the postoperative pulmonary complications. 
10. Post thoracotomy anaesthetic management based on predicted postop 
FEV1 







>40 %                                      40-30%                                  30-20% 
 Extubate in OR                       Extubate if other factors                    Consider Extubation If all 
                                                   are favourable                                    are favourable with Thoracic 
                                                                                                                 Epidural Analgesia 
                                                                               
If Alert, warm                          Exercise Tolerance, DLCO               other patients: 
Comfortable                             V/Q Scan, Associated diseases       Staged wean of Ventilation.  
 
Courtesy of Slinger and Johnson 
Fig. 6. 
11. Imaging studies 
Assessment of patient anatomy is important in order to anticipate a difficult endotracheal, 
or endobronchial intubation. Any deviation of the trachea from the midline should alert the 
anaesthetists to a potentially difficult intubation or to the possibility of airway obstruction 
during induction of anaesthesia. In addition to the physical exam, Chest X-rays, CT scans, 
and bronchoscopy reports can all be of use.  Important factors include tumour that impinges 
on the chest wall, traverses the fissures between lobes or is in close proximity to major 
vessels. In some cases, and where available, a PET scan (positron emission tomography) 
may be performed to further identify the anatomy of the tumour and to clarify whether 
nodal spread or metastasis has occurred (Figure2). As an anaesthetist it is important to view 
these scans in order to understand the planned surgery(27). For example: 
• chest wall resection may be necessary, 
• close proximity to the pleura with pleural resection may make paravertebral analgesia 
impossible, 
• proximity to the pulmonary vessels or aorta makes major blood loss more likely. 
www.intechopen.com
 
Preoperative Evaluation of Patients for Thoracic Surgery 
 
13 










Surgical pulmonary resection and chemo radiotherapy both induce significant mortality and 
morbidity in lung cancer patients. A targeted preoperative assessment combined with 
multidisciplinary approach can help individualize the morbidity and mortality risk of 
surgery for each patient and provide the surgeon and patient with the information needed 
for operative decision making. 
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